NAD-Dependent Protein Deacetylase Sirtuin-1 Mediated Mitophagy Regulates Early Brain Injury After Subarachnoid Hemorrhage
Gen Wang,Ning Lin
DOI: https://doi.org/10.2147/jir.s451922
IF: 4.5
2024-03-29
Journal of Inflammation Research
Abstract:Gen Wang, Ning Lin Department of Neurosurgery, The Affiliated Chuzhou Hospital of Anhui Medical University (The First People's Hospital of Chuzhou), Chuzhou, Anhui Province, People's Republic of China Correspondence: Ning Lin, Email Background: This study focuses on the role of SIRT1 in neuroinflammation caused by early brain injury (EBI) after subarachnoid hemorrhage (SAH), and explores its mechanism in mitophagy after SAH. Methods: C57BL/6J mice and primary microglia SAH in vivo and in vitro models were constructed to explore the expression level of SIRT1 in neuroinflammation after SAH. Subsequently, the brain edema content, blood–brain barrier (BBB) damage and neurological function scores of the mice were observed after using the SIRT1 inhibitor EX-527. q-PCR and Western blot were used to detect relevant genes and proteins, and enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of IL-6, IL-1β, and TNF-α inflammatory factors. Immunofluorescence staining was used to observe the positive level of SIRT1 and the degree of mitochondria-lysosome fusion, and transmission electron microscopy was used to observe mitochondrial damage and autophagosome levels. Results: In in vivo and in vitro experiments, we found that SIRT1 expression increased after SAH, and neurological deficits, brain edema, and blood–brain barrier damage after SAH were aggravated. Inhibiting SIRT1 further aggravates the aforementioned damage. In addition, EX-527 can also inhibit the level of mitophagy and aggravate neuroinflammation after SAH. Conclusion: Our results indicated that SIRT1 promotes mitophagy and alleviates neuroinflammation after SAH. Keywords: subarachnoid hemorrhage, SIRT1, mitophagy, early brain injury Subarachnoid hemorrhage (SAH) is a severe hemorrhagic cerebrovascular disease, which mainly caused by the rupture of aneurysm in clinically and is one of the most devastating cerebrovascular diseases. One-third of the patients usually die at the time, and the other one-third develop permanent disability, which seriously affects the patient's quality of life. 1–3 Studies 4,5 have found that early brain injury (EBI) is one of the pivotal factors causing this outcome after SAH. EBI involves a variety of physiological disorders, including neuroinflammatory injury, blood–brain barrier disruption, nerve cell apoptosis, etc. and neuroinflammation plays a vital role in EBI. 6,7 Therefore, a deeper understanding of the neuroinflammation in EBI may provide new preventive strategies for SAH patients. Evidences have shown that microglia participate in the immune response of the central nervous system and participate in the regulation of inflammatory factor levels through cell phenotype conversion after SAH. However, the mechanisms that lead to microglial inflammation after SAH have not yet been clearly understood. Therefore, targeting the microglial inflammatory response may help search for therapeutic targets for SAH. NAD-dependent protein deacetylase sirtuin-1 (SIRT1) is one of the most well-studied members of the Sirtuin family. Which mainly distributes in the nucleus and cytoplasm, and participates in the regulation of DNA damage repair, such as oxidative stress, immune response, mitochondrial biogenesis and apoptosis/autophagy by exercising its NAD + dependent deacetylation activity. 8–10 Previous studies have shown that SIRT1 can not only be expressed in microglia, but also participate in neuroprotective effects by regulating microglia function in SAH. Chen et al 11 used 2,3,5,6-tetramethylpyrazine to activate SIRT1 in BV2 cell, which alleviated neuroinflammation after SAH by inhibiting M1 microglial polarization; Arc could regulate brain injury and neuroinflammation after SAH through SIRT1 in a SAH mouse; 12 in addition, SIRT1 could promote M2 microglia polarization by reducing ROS-mediated NLRP3 inflammasome signaling and alleviate neuroinflammatory damage after SAH. 13 What's more, SIRT1 can also play a role in the central nervous system by participating in regulating mitophagy. Yao et al 14 induced autophagic cell death/mitophagy through activators of SIRT1 as a potential therapeutic strategy for glioblastoma. TUG1 knockdown promotes SIRT1-induced mitophagy by inhibiting FBXW7-mediated degradation of SIRT1, thereby alleviating neuronal apoptosis induced by cerebral ischemia-reperfusion injury. 15 Of course, there are also studies reported the role of mitophagy in SAH. T3 promotes mitophagy through the PINK1-parkin pathway and alleviates EBI after SAH. 16 Zhang et al 17 reported that NL-1 promotes PINK1-Parkin-mediated mitophagy through MitoNEET inhibition in SAH and reduces EBI after SAH in rats. Liu et al -Abstract Truncated-
immunology